Headlines

REGN

Biotech ETFs Flash Classic Reversal Signal

Biotech is emerging as a leadership pocket, with SPDR S&P Biotech ETF (XBI) and Direxion Daily S&P Biotech Bull 3x Shares (LABU) showing notable relative strength into a session where both surged...

April 1, 2026

2 min read

Japan clears Dupixent for bullous pemphigoid

Sanofi's Dupixent wins Japanese nod for rare blistering disease after strong Phase 2/3 results; Q1 memo out.

Mar 24, 2026

4 min read

Goldman’s Top Healthcare Picks Gain Fresh Catalysts

Clinical wins and analyst upgrades spark renewed momentum across big pharma and biotech stocks.

Mar 15, 2026

4 min read

Institutions Boost Stakes in Regeneron

Mixed institutional flows reshape Regeneron momentum after a stronger quarter and upgraded outlook.

Mar 15, 2026

4 min read

Institutional Moves in Major U.S. Equities

Institutional reallocations and exec stock sales prompt analysts to keep conservative stances.

Mar 12, 2026

4 min read

2025 Valuation Insights: Spotify, Aker BP, and Key Growth Stocks

Spotify's growth shines amid valuation risks; Aker BP's gains face premium multiples in mixed market outlook.

Dec 7, 2025

5 min read